Efficacy Evaluation of Quercetin and Its Analogues on the Main Protease Enzyme of the COVID-19 Using Molecular Docking Studies
Open Access
- 1 October 2022
- journal article
- Published by CMV Verlag in Journal of Ilam University of Medical Sciences
- Vol. 30 (4), 66-85
- https://doi.org/10.52547/sjimu.30.4.66
Abstract
Introduction: COVID-19 is an acute respiratory infectious disease caused by the SARS-CoV-2 virus. There is an urgent need to discover antiviral drugs for better performance against new strains of coronaviruses (CoVs) due to the rapid spread of the disease despite scientific advances in vaccine development. This study aimed to evaluate ...Keywords
This publication has 40 references indexed in Scilit:
- Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology, 2018
- The structure and functions of coronavirus genomic 3′ and 5′ endsVirus Research, 2015
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaThe New England Journal of Medicine, 2012
- PASS-assisted exploration of new therapeutic potential of natural productsMedicinal Chemistry Research, 2010
- Identification of a new human coronavirusNature Medicine, 2004
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeThe New England Journal of Medicine, 2003
- Simple Selection Criteria for Drug-like Chemical MatterJournal of Medicinal Chemistry, 2001
- Neuroinvasion by Human Respiratory CoronavirusesJournal of Virology, 2000
- Prediction of Drug Absorption Using Multivariate StatisticsJournal of Medicinal Chemistry, 2000
- Drug-like properties and the causes of poor solubility and poor permeabilityJournal of Pharmacological and Toxicological Methods, 2000